*ST eDiagnosis announced that as of June 22, 2026, the company completed its share repurchase, having repurchased a total of 9.436952 million shares through centralized bidding transactions, accounting for 4.06% of the total share capital, with a highest transaction price of 17.5 yuan/share and a lowest of 15.13 yuan/share, for a total payment of 154 million yuan. The sources of funds for this repurchase, quantity, price, etc., comply with the plan, and the relevant parties did not buy or sell the company's stock during the repurchase period. The repurchased shares will be sold at an opportune time after 12 months, to be completed within 3 years, and any unsold shares will be canceled